Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Pineo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|March 12, 2003
Coumarin therapy in thrombosisGraham Pineo, Russell D Hull
Best Practice & Research. Clinical Haematology|June 3, 2004
Oral delivery of heparin: SNAC and related formulationsGraham Pineo, Russell Hull, Victor Marder
Journal of Hospital Medicine|November 8, 2011
Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trialGraham Pineo, Jay Lin, Lee Stern, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Economic impact of enoxaparin after acute ischemic stroke based on PREVAILGraham Pineo, Jay Lin, Lee Stern, et al.
Lancet (London, England)|March 9, 2010
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
The New England Journal of Medicine|August 7, 2009
Apixaban or enoxaparin for thromboprophylaxis after knee replacementMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
The New England Journal of Medicine|December 24, 2010
Apixaban versus enoxaparin for thromboprophylaxis after hip replacementMichael Rud Lassen, Alexander Gallus, Gary E Raskob, et al.
International Journal of Hematology|August 1, 2008
Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpuraShannon C Jackson, Paul Beck, Andre G Buret, et al.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for hematologic conditionsDavid Anderson, Kaiser Ali, Victor Blanchette, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|March 12, 2003
Coumarin therapy in thrombosisGraham Pineo, Russell D Hull
Best Practice & Research. Clinical Haematology|June 3, 2004
Oral delivery of heparin: SNAC and related formulationsGraham Pineo, Russell Hull, Victor Marder
Journal of Hospital Medicine|November 8, 2011
Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trialGraham Pineo, Jay Lin, Lee Stern, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Economic impact of enoxaparin after acute ischemic stroke based on PREVAILGraham Pineo, Jay Lin, Lee Stern, et al.
Lancet (London, England)|March 9, 2010
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
The New England Journal of Medicine|August 7, 2009
Apixaban or enoxaparin for thromboprophylaxis after knee replacementMichael Rud Lassen, Gary E Raskob, Alexander Gallus, et al.
The New England Journal of Medicine|December 24, 2010
Apixaban versus enoxaparin for thromboprophylaxis after hip replacementMichael Rud Lassen, Alexander Gallus, Gary E Raskob, et al.
International Journal of Hematology|August 1, 2008
Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpuraShannon C Jackson, Paul Beck, Andre G Buret, et al.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for hematologic conditionsDavid Anderson, Kaiser Ali, Victor Blanchette, et al.
Pageof 1